Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression

Development

Volumn 127, Issue 18, 2000, Pages 3941-3946

  Miquerol, L ^a   Langille, B L ^a   Nagy, A ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardiogenesis; Coronary development; Gene regulation; Mouse; Septation; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EMBRYO DEVELOPMENT; GENE LOCUS; GENE OVEREXPRESSION; HEART BLOOD VESSEL; HEART DEVELOPMENT; HEART MUSCLE; HEART VENTRICLE SEPTUM DEFECT; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

3' UNTRANSLATED REGIONS; ANIMAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FETAL DEATH; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HEART; HEART DEFECTS, CONGENITAL; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICE; MYOCARDIUM; PHENOTYPE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; UP-REGULATION;

EID: 0033793921     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Constitutive expression of ph VEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
2. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
3. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability
6. The FMS-like tyrosine kinase, a receptor for vascular endothelial growth factor
7. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements
8. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2-and heregulin-deficient mice
9. Heterozygous embryonic lethality induced by targetted inactivation of the VEGF gene
10. Pituitary follicular cells produce basic fibroblast growth factor
11. VEGF induces cardiovascular malformation and embryonic lethality
12. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation
13. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
14. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
15. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
16. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
17. VEGF is required for growth and survival in neonatal mice
18. Hypoxia-induced transcriptional activation and increased mRNA stability of VEGF in C6 glioma cells
19. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation
20. Requirement for neuregulin receptor erbB2 in neural and cardiac development
21. Vascular endothelial growth factor is a secreted angiogenic mitogen
22. Transcriptional regulation of the rat VEGF gene by hypoxia
23. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
24. Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): Conservation of five hypoxia-inducible RNA-protein binding sites
25. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer
26. Z/AP, a double reporter for cre-mediated recombination
27. Conditional genome alteration in mice
28. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of ph VEGF165 as sole therapy for myocardial ischemia
29. Multiple essential functions of neuregulin in development
30. Retroviral analysis of cardiac morphogenesis: Discontinuous formation of coronary vessels
31. High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis
32. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
33. Endothelial receptor tyrosine kinases involved in angiogenesis
34. Production and analysis of ES cell aggregation chimeras
35. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells
36. Changes in the microvascular network during cardia growth, development, and aging
37. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
38. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
39. Nucleotide sequence and expression of a novel Human receptor-type tyrosine kinasegene (flt) closely related to the fms family
40. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation
41. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis
42. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene